Hera BioLabs

Hera BioLabs

Biotechnology Research

Lexington, KY 999 followers

CRO services with our SRG rat (OncoRat) and Cas-CLOVER & piggyBac gene editing technologies

About us

Hera Biolabs is an innovative preclinical service and technology provider with novel gene-editing and rat model creation technologies. We created the SRG™ rat, the first commercially available highly immunocompromised rat model, which has been validated for oncology and used routinely for human tumor xenograft studies (OncoRat®). We also have our own proprietary gene-editing technologies, piggyBac transposon and the Cas-CLOVER targeted nuclease system, platforms used for cell-line modification and animal model creation. Hera makes available to researchers in academia and industry our gene-editing technologies and products, as well as our SRG rat. Hera also provides services in these areas, performing cell engineering and in vitro and in vivo oncology studies for clients. Hera conducts all work with excellent scientific rigor and customer service at our laboratories, with a state-of-the art vivarium, in beautiful Lexington, KY.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Lexington, KY
Type
Privately Held
Founded
2014
Specialties
preclinical oncology services, Cancer xenografts, Humanized immune system rodents, immuno-oncology, SRG rat, Gene Editing, patient derived xenografts PDX, NSG mice, NOG mice, transgenic rodent creation, piggyBac, and Cas-CLOVER

Locations

Employees at Hera BioLabs

Updates

Similar pages

Browse jobs

Funding

Hera BioLabs 2 total rounds

Last Round

Series unknown

US$ 1.1M

See more info on crunchbase